Skip to main content
Fig. 3 | Antimicrobial Resistance & Infection Control

Fig. 3

From: Drug-resistance characteristics, genetic diversity, and transmission dynamics of multidrug-resistant or rifampicin-resistant Mycobacterium tuberculosis from 2019 to 2021 in Sichuan, China

Fig. 3

Drug resistance and gene mutation types in 278 MDR/RR-TB strains. Note The X-axis was each drug based on drug mutations and gene mutation types. The Y-axis was the percentage of isolates containing the drug mutation. MDR/RR-TB, multidrug- or rifampicin-resistant tuberculosis; RFP, rifampicin; INH, isoniazid; EMB, ethambutol; PZA, pyrazinamide; SM, streptomycin; AM, amikacin; CM, capreomycin; KM, kanamycin; FQs, fluoroquinolones; ETO, ethionamide; PAS, para-aminosalicylic acid; CFZ, clofazimine; BDQ, bedaquiline; DEL, delamanid

Back to article page